Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells. 2005

Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
Department of Dermatology, University of Occupational and Environmental Health, 1-1 Iseogaoka, Yahatanishi-ku, Kitakyusyu 807-8555, Japan. t-shima@med.uoeh-u.ac.jp

OBJECTIVE Adult T-cell leukemia/lymphoma (ATL) is a peripheral CD4(+)CD25(+) T-cell malignancy caused by human T-cell leukemia virus type I. The tumor cells frequently infiltrate in the skin, lymph nodes and other organs and especially form prominent cutaneous masses. Recently, ATL cells have been shown to express Th2 chemokine receptor CCR4. The aim of this study is to investigate the possibility that CCR4 ligands, thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC), are produced by CCR4(+) ATL cells per se. METHODS CD4(+) or CD4(+)CD14(-) cells were purified from peripheral blood mononuclear cells of 11 ATL patients with cutaneous involvement and normal healthy volunteers. Tissue-infiltrating cells were isolated from skin tumors. The expression of chemokine receptors on these cells were analyzed by flow cytometry. The production of chemokines and cytokines by the neoplastic cells was assessed by ELISA and reverse transcription-PCR after cultivation for 96 hours in the presence or absence of anti-CD3/CD28 monoclonal antibodies. Finally, TARC and CCR4 expressions were examined by immunohistochemistry. RESULTS ATL cells highly expressed CCR4 but did not necessarily exhibit the Th2 cytokine profile. The cells also produced TARC and MDC. The production level of MDC was higher in the skin tumor formation group than that in the nontumor group. Immunohistochemically, both CCR4 and TARC were expressed by the tumor cells in the lesional skin. CONCLUSIONS ATL cells not only express CCR4 but also produce TARC and MDC. The skin tumor formation as well as the monoclonal integration of proviral DNA are the factors that are associated with the high production of Th2 chemokines by ATL cells.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
August 2009, Respiratory research,
Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
January 2013, International archives of allergy and immunology,
Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
June 2013, Journal of neuroinflammation,
Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
September 2012, Current hematologic malignancy reports,
Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
May 2005, Allergy,
Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
May 1975, Experientia,
Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
April 2000, Journal of immunology (Baltimore, Md. : 1950),
Takatoshi Shimauchi, and Satoshi Imai, and Ryosuke Hino, and Yoshiki Tokura
March 2003, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!